Pediatric posterior fossa tumor

• Integrating Radiomics and Lesion Mapping for Cerebellar Mutism Syndrome Prediction
• Neuropsychological outcome in pediatric brain tumor survivors treated with proton radiation prior to age 4 years
• Delivery of LOXL1-AS1-siRNAs using targeting peptide-engineered extracellular vesicles with focused ultrasound to suppress medulloblastoma metastasis
• Volumetric predictors for shunt-dependency in pediatric posterior fossa tumors
• Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma
• Endocrine Comorbidities in Survivors of Childhood Brain Tumors: Insights from the Slovenian National Cohort
• Exploring the tumor microenvironment in diffuse intrinsic pontine glioma: immunological insights and therapeutic challenges
• Preventing What Matters: A Fast and Reliable Technique to Secure External Ventricular Drains and Avoid Dislodgement

Approximately half of pediatric central nervous system tumors are located in the posterior fossa.

Pilocytic astrocytomas (PAs), medulloblastomas (MBs), and ependymomas are the most common posterior fossa tumors.

High-grade gliomas, atypical teratoid/rhabdoid tumor, and choroid plexus papilloma of the fourth ventricle are less frequent.

Because of the different treatment options and variability in long-term outcome, an accurate and specific diagnosis is mandatory ¹⁾.

Pediatric posterior fossa tumor classification.

Pediatric posterior fossa tumor diagnosis.

Pediatric posterior fossa tumor differential diagnosis.

Pediatric posterior fossa tumor treatment.

Posterior fossa tumors tend to entail obstructive hydrocephalus, and urges initiating prompt treatment.

see Postoperative hydrocephalus

Pediatric posterior fossa tumor outcome.

Pediatric posterior fossa tumor case series